{"title":"转移性淋巴结中的常驻记忆T细胞与胃癌患者良好预后相关","authors":"Masaki Nishiyama, Yuichiro Miki, Hiroaki Tanaka, Seiji Natsuki, Kenji Kuroda, Mami Yoshii, Tatsuro Tamura, Takahiro Toyokawa, Shigeru Lee, Kiyoshi Maeda","doi":"10.1111/cas.70163","DOIUrl":null,"url":null,"abstract":"<p>Infiltration of resident memory T cells (TRMs) in the main tumor has been reported as a favorable prognostic factor. However, the role of TRMs in the lymph nodes (LNs) remains unclear. Thus, we examined the prognostic impact of TRMs infiltration within LNs of patients with gastric cancer (GC). Among 151 patients with metastasis to LN station No. 3, we classified them into two groups (CD103<sup>hi</sup> and CD103<sup>lo</sup>) based on the number of CD103<sup>+</sup> T cells using immunohistochemical staining and analyzed the association between these groups and survival outcomes. We also examined the phenotype of CD8<sup>+</sup> CD103<sup>+</sup> T cells in the metastatic LNs using flow cytometry. Among patients with LN metastasis, metastasis to LN station No. 3 was significantly associated with a poor prognosis. There was a significant correlation between the number of CD8<sup>+</sup> CD103<sup>+</sup> T cells between the main lesion and the metastatic LNs. CD103<sup>hi</sup> was associated with a favorable prognosis (5-year overall survival [OS], log-rank <i>p</i> = 0.001; 5-year recurrence free survival [RFS], log-rank <i>p</i> = 0.001). Among adjuvant chemotherapy cases, patients with CD103<sup>hi</sup> exhibited significantly better OS and RFS than those with CD103<sup>lo</sup> (OS, log-rank <i>p</i> < 0.001; RFS, log-rank <i>p</i> < 0.001). Flow cytometry revealed that PD-1 expression in CD8<sup>+</sup> CD103<sup>+</sup> T cells was higher in metastatic than in normal LNs. Among patients with CD103<sup>hi</sup>, those with high PD-1 expression exhibited significantly better OS than those with low PD-1 expression. In conclusion, the infiltration of TRMs into LNs is a critical prognostic factor in GC.</p>","PeriodicalId":9580,"journal":{"name":"Cancer Science","volume":"116 10","pages":"2688-2698"},"PeriodicalIF":4.3000,"publicationDate":"2025-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cas.70163","citationCount":"0","resultStr":"{\"title\":\"Resident Memory T Cell in Metastatic Lymph Nodes Is Associated With Favorable Prognosis in Gastric Cancer Patients\",\"authors\":\"Masaki Nishiyama, Yuichiro Miki, Hiroaki Tanaka, Seiji Natsuki, Kenji Kuroda, Mami Yoshii, Tatsuro Tamura, Takahiro Toyokawa, Shigeru Lee, Kiyoshi Maeda\",\"doi\":\"10.1111/cas.70163\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Infiltration of resident memory T cells (TRMs) in the main tumor has been reported as a favorable prognostic factor. However, the role of TRMs in the lymph nodes (LNs) remains unclear. Thus, we examined the prognostic impact of TRMs infiltration within LNs of patients with gastric cancer (GC). Among 151 patients with metastasis to LN station No. 3, we classified them into two groups (CD103<sup>hi</sup> and CD103<sup>lo</sup>) based on the number of CD103<sup>+</sup> T cells using immunohistochemical staining and analyzed the association between these groups and survival outcomes. We also examined the phenotype of CD8<sup>+</sup> CD103<sup>+</sup> T cells in the metastatic LNs using flow cytometry. Among patients with LN metastasis, metastasis to LN station No. 3 was significantly associated with a poor prognosis. There was a significant correlation between the number of CD8<sup>+</sup> CD103<sup>+</sup> T cells between the main lesion and the metastatic LNs. CD103<sup>hi</sup> was associated with a favorable prognosis (5-year overall survival [OS], log-rank <i>p</i> = 0.001; 5-year recurrence free survival [RFS], log-rank <i>p</i> = 0.001). Among adjuvant chemotherapy cases, patients with CD103<sup>hi</sup> exhibited significantly better OS and RFS than those with CD103<sup>lo</sup> (OS, log-rank <i>p</i> < 0.001; RFS, log-rank <i>p</i> < 0.001). Flow cytometry revealed that PD-1 expression in CD8<sup>+</sup> CD103<sup>+</sup> T cells was higher in metastatic than in normal LNs. Among patients with CD103<sup>hi</sup>, those with high PD-1 expression exhibited significantly better OS than those with low PD-1 expression. In conclusion, the infiltration of TRMs into LNs is a critical prognostic factor in GC.</p>\",\"PeriodicalId\":9580,\"journal\":{\"name\":\"Cancer Science\",\"volume\":\"116 10\",\"pages\":\"2688-2698\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-08-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cas.70163\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/cas.70163\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Science","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cas.70163","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
常驻记忆T细胞(TRMs)在主要肿瘤的浸润已被报道为一个有利的预后因素。然而,TRMs在淋巴结(LNs)中的作用尚不清楚。因此,我们研究了胃癌(GC)患者ln内TRMs浸润对预后的影响。在151例LN 3号站转移患者中,我们采用免疫组化染色方法,根据CD103+ T细胞的数量将其分为CD103hi和CD103lo两组,并分析这两组患者与生存结果的关系。我们还使用流式细胞术检测了转移性LNs中CD8+ CD103+ T细胞的表型。在有淋巴结转移的患者中,转移到淋巴结3号站与预后不良显著相关。CD8+ CD103+ T细胞数量在主病变与转移灶之间有显著相关性。CD103hi与良好的预后相关(5年总生存率[OS], log-rank p = 0.001;5年无复发生存率(RFS), log-rank p = 0.001)。在辅助化疗病例中,CD103hi患者的OS和RFS明显优于CD103lo患者(OS, log-rank p + CD103+ T细胞的转移率高于正常LNs)。在CD103hi患者中,PD-1高表达患者的OS明显优于PD-1低表达患者。总之,TRMs向LNs的浸润是GC的关键预后因素。
Resident Memory T Cell in Metastatic Lymph Nodes Is Associated With Favorable Prognosis in Gastric Cancer Patients
Infiltration of resident memory T cells (TRMs) in the main tumor has been reported as a favorable prognostic factor. However, the role of TRMs in the lymph nodes (LNs) remains unclear. Thus, we examined the prognostic impact of TRMs infiltration within LNs of patients with gastric cancer (GC). Among 151 patients with metastasis to LN station No. 3, we classified them into two groups (CD103hi and CD103lo) based on the number of CD103+ T cells using immunohistochemical staining and analyzed the association between these groups and survival outcomes. We also examined the phenotype of CD8+ CD103+ T cells in the metastatic LNs using flow cytometry. Among patients with LN metastasis, metastasis to LN station No. 3 was significantly associated with a poor prognosis. There was a significant correlation between the number of CD8+ CD103+ T cells between the main lesion and the metastatic LNs. CD103hi was associated with a favorable prognosis (5-year overall survival [OS], log-rank p = 0.001; 5-year recurrence free survival [RFS], log-rank p = 0.001). Among adjuvant chemotherapy cases, patients with CD103hi exhibited significantly better OS and RFS than those with CD103lo (OS, log-rank p < 0.001; RFS, log-rank p < 0.001). Flow cytometry revealed that PD-1 expression in CD8+ CD103+ T cells was higher in metastatic than in normal LNs. Among patients with CD103hi, those with high PD-1 expression exhibited significantly better OS than those with low PD-1 expression. In conclusion, the infiltration of TRMs into LNs is a critical prognostic factor in GC.
期刊介绍:
Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association. First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research. The Journal also accepts reports and case reports.
Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result. Review articles may also be published.